These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32787149)

  • 1. Injectable Anti-inflammatory Nanofiber Hydrogel to Achieve Systemic Immunotherapy Post Local Administration.
    Chen M; Tan Y; Dong Z; Lu J; Han X; Jin Q; Zhu W; Shen J; Cheng L; Liu Z; Chen Q
    Nano Lett; 2020 Sep; 20(9):6763-6773. PubMed ID: 32787149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.
    Cheng F; Su T; Zhou S; Liu X; Yang S; Lin S; Guo W; Zhu G
    Sci Adv; 2023 Jul; 9(28):eade6257. PubMed ID: 37450588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment.
    Fang T; Cao X; Shen B; Chen Z; Chen G
    Biomaterials; 2023 Sep; 300():122189. PubMed ID: 37307777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer.
    Wang F; Su H; Xu D; Monroe MK; Anderson CF; Zhang W; Oh R; Wang Z; Sun X; Wang H; Wan F; Cui H
    Biomaterials; 2021 Dec; 279():121182. PubMed ID: 34688987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the bioresponsive adhesion of immuno-bioglue for enhanced local immune checkpoint blockade therapy.
    Joo KI; Jeong Y; Hwang SM; Shin M; Lee J; Sharma G; Lee H; Im SH; Cha HJ
    Biomaterials; 2020 Dec; 263():120380. PubMed ID: 32942128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade.
    Yu S; Wang C; Yu J; Wang J; Lu Y; Zhang Y; Zhang X; Hu Q; Sun W; He C; Chen X; Gu Z
    Adv Mater; 2018 Jul; 30(28):e1801527. PubMed ID: 29786888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy.
    Gao C; Cheng K; Li Y; Gong R; Zhao X; Nie G; Ren H
    Nano Lett; 2022 Nov; 22(22):8801-8809. PubMed ID: 36251255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL release from self-assembling nanofiber hydrogels for inducing osteoclastogenesis in vitro.
    Xing JZ; Lu L; Unsworth LD; Major PW; Doschak MR; Kaipatur NR
    Acta Biomater; 2017 Feb; 49():306-315. PubMed ID: 27940164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C supramolecular hydrogel for enhanced cancer immunotherapy.
    Zhang H; Liu K; Gong Y; Zhu W; Zhu J; Pan F; Chao Y; Xiao Z; Liu Y; Wang X; Liu Z; Yang Y; Chen Q
    Biomaterials; 2022 Aug; 287():121673. PubMed ID: 35839587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment.
    Chen Z; Rong Y; Ding J; Cheng X; Chen X; He C
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy.
    Yang A; Sheng S; Bai Y; Xing G; Yu X; Zhu D; Mei L; Dong X; Lv F
    Acta Biomater; 2022 Nov; 153():124-138. PubMed ID: 36179979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd single atom nanozymes as a localized immunomodulation niche for cancer catalytic immunotherapy.
    He H; Fei Z; Guo T; Hou Y; Li D; Wang K; Ren F; Fan K; Zhou D; Xie C; Wang C; Lu X
    Biomaterials; 2022 Jan; 280():121272. PubMed ID: 34864428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy.
    Wang F; Xu D; Su H; Zhang W; Sun X; Monroe MK; Chakroun RW; Wang Z; Dai W; Oh R; Wang H; Fan Q; Wan F; Cui H
    Sci Adv; 2020 May; 6(18):eaaz8985. PubMed ID: 32490201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune-Based Combination Therapy.
    Ma H; He C; Chen X
    Macromol Biosci; 2021 Jun; 21(6):e2100039. PubMed ID: 33818918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy.
    Fan Y; Zhan M; Liang J; Yang X; Zhang B; Shi X; Hu Y
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302119. PubMed ID: 37541435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kim J; Francis DM; Thomas SN
    Nanomaterials (Basel); 2021 Feb; 11(2):. PubMed ID: 33673289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.